PG
BSX icon

Portola Group’s Boston Scientific BSX Stock Holding History

Portola Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-23,608
Closed -$277K – 86
2013
Q3 		$277K Hold
23,608
– – 0.17% 77
2013
Q2 		$219K Buy
+23,608
New +$200K 0.15% 65

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Portola Group's BSX Position: Q4 2013 in Review

Portola Group sold out of Boston Scientific (BSX) in Q4 2013, closing a stake of 23,608 shares — an estimated $277K sold.

Portola Group first reported a position in BSX in Q2 2013 and held it in 2 quarters. The position peaked at $277K in Q3 2013. 452 funds tracked by Wall St. Rank hold BSX as of Q4 2013.

  • Portola Group reported no remaining Boston Scientific position as of Q4 2013 after selling out during the quarter.
  • Portola Group sold 23,608 Boston Scientific shares in Q4 2013, an estimated $277K.
  • Portola Group first reported a position in Boston Scientific in Q2 2013 and held it in 2 quarters.
  • Portola Group's Boston Scientific position peaked at $277K in Q3 2013.
  • 452 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2013.

Based on Portola Group's 13F filing for Q4 2013, filed 14 Feb 2014.